Literature DB >> 17095233

Synthesis and c-Src inhibitory activity of imidazo[1,5-a]pyrazine derivatives as an agent for treatment of acute ischemic stroke.

Harunobu Mukaiyama1, Toshihiro Nishimura, Satoko Kobayashi, Tomonaga Ozawa, Noboru Kamada, Yoshimitsu Komatsu, Shinji Kikuchi, Hideki Oonota, Hiroshi Kusama.   

Abstract

We synthesized and evaluated a series of C-5 substituted imidazo[1,5-a]pyrazine derivatives to identify potent c-Src inhibitors as potential therapeutic agents for acute ischemic stroke. Among these compounds, compound 14c.HCl demonstrated remarkable central nervous system (CNS) penetration and significant neuroprotective efficacy in vivo in rat models.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17095233     DOI: 10.1016/j.bmc.2006.10.041

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  16 in total

1.  Multidimensional Screening and Methodology Development for Condensations Involving Complex 1,2-Diketones.

Authors:  John R Goodell; Bo Leng; Tracy K Snyder; Aaron B Beeler; John A Porco
Journal:  Synthesis (Stuttg)       Date:  2010-07-01       Impact factor: 3.157

2.  Efficient microwave-assisted Suzuki-Miyaura cross-coupling reaction of 3-bromo pyrazolo[1,5-a]pyrimidin-5(4H)-one: towards a new access to 3,5-diarylated 7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine derivatives.

Authors:  Badr Jismy; Gérald Guillaumet; Mohamed Akssira; Abdellatif Tikad; Mohamed Abarbri
Journal:  RSC Adv       Date:  2021-01-04       Impact factor: 4.036

3.  N'-[1-(4-Amino-phen-yl)ethyl]pyrazine-2-carbohydrazide.

Authors:  Zhi-Yong Xing; De-Cheng Yu; Lai-Jun Li; Hai-Yan Liu; Jian-Fei Zhang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-02-06

4.  Hsp27 inhibits sublethal, Src-mediated renal epithelial cell injury.

Authors:  Andrea Havasi; Zhiyong Wang; Jonathan M Gall; Max Spaderna; Vikram Suri; Ellery Canlas; Jody L Martin; John H Schwartz; Steven C Borkan
Journal:  Am J Physiol Renal Physiol       Date:  2009-06-24

5.  N-tert-Butyl-2-(2,6-di-chloro-phen-yl)imidazo[1,2-a]pyrazin-3-amine.

Authors:  Zeenat Fatima; Thothadri Srinivasan; Suman Koorathota; Sathiah Thennarasu; Devadasan Velmurugan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-05-25

6.  Methyl 3,5-bis-[(3-chloro-pyrazin-2-yl)-oxy]benzoate.

Authors:  Thothadri Srinivasan; Venkatesan Kalpana; Perumal Rajakumar; Devadasan Velmurugan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-04-20

7.  1,3-Bis[(3-chloro-pyrazin-2-yl)-oxy]benzene.

Authors:  Thothadri Srinivasan; Venkatesan Kalpana; Perumal Rajakumar; Devadasan Velmurugan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-04-30

8.  1,4-Bis(3-chloro-pyrazin-2-yl-oxy)benzene.

Authors:  Thothadri Srinivasan; Venkatesan Kalpana; Perumal Rajakumar; Devadasan Velmurugan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-03-28

9.  8,15-Dioxa-10,13-di-aza-tetra-cyclo-[14.4.0.0(2,7).0(9,14)]icosa-1(16),2,4,6,9(14),10,12,17,19-nona-ene.

Authors:  Thothadri Srinivasan; Venkatesan Kalpana; Perumal Rajakumar; Devadasan Velmurugan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-04-30

10.  N-tert-Butyl-2-[4-(dimethyl-amino)-phen-yl]imidazo[1,2-a]pyrazin-3-amine.

Authors:  Zeenat Fatima; Thothadri Srinivasan; Suman Koorathota; Sathiah Thennarasu; Devadasan Velmurugan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.